The economist who decided that the most persuasive thing in a B2B sales conversation is arithmetic the customer can check.
Every salesperson eventually meets the moment. The customer leans back, folds their arms, and asks why this costs what it costs. Most teams reach for a brochure. Peyton Marshall built a company so they could reach for a number instead - one the buyer can poke, question, and verify on the spot. That company is LeveragePoint, a software business in Newton, Massachusetts, and it exists because Marshall believes value should be a calculation, not a claim.
Today he is its founder, Chairman, and CEO. LeveragePoint sells a cloud platform that lets B2B companies build interactive value propositions and ROI tools - the kind a seller and a buyer can open together and adjust live. It is value-based pricing turned into a button you can press. The premise sounds almost too tidy: if you can prove the economic value your product creates, you can price for it and sell it without apology. Marshall has spent more than a decade making that idea practical rather than academic.
What makes the bet credible is who is making it. Marshall is an economist by training, with an AB from Davidson College and a PhD in economics from MIT. He has stood at the front of a Vanderbilt classroom teaching the subject. He has also sat on the other side of the table, where economics stops being elegant and starts being money.
Before software, there was banking. Marshall spent twelve years as an investment banker in London - first at Union Bank of Switzerland, then at Goldman Sachs, where he became head of European product development. Product development at a bank means inventing the instruments other people trade. It is a job about structuring value precisely, which turns out to be useful training for someone who would later argue that most companies describe their value far too loosely.
He then spent roughly fifteen years as a senior operator in healthcare and IT companies, almost always holding the finance brief. He was CFO of The Medicines Company, steering it through its initial public offering and the commercial launch of Angiomax. He was CFO of EPIX Pharmaceuticals. He was CFO and, for a stretch, Acting CEO of Panacos Pharmaceuticals. These are the rooms where a product's worth gets translated into a price, a forecast, and a story for investors - and where the gap between what something is worth and what a company can actually capture becomes painfully concrete.
That gap is the whole reason LeveragePoint exists. Marshall watched good products struggle to be paid for what they delivered, not because the value wasn't there, but because nobody had a clean way to show it. Sales teams improvised. Pricing got anchored to cost. The customer's own business case stayed fuzzy. An economist looks at that and sees a measurement problem hiding inside a communication problem.
The IdeaMarshall's thinking is sharpest when he refuses the obvious question. Ask most pricing consultants “what percent of the value should we capture?” and they reach for a comforting number, often a tidy fifty percent. Marshall argues the question itself is the trap. It is seller-centric. It treats a relationship as a single transaction. And it pretends there is one right answer regardless of the market you are in.
His reframe: stop asking what slice to grab in a single deal, and start asking what policies let you capture meaningful value over many deals and many years. A single sale is a snapshot. A business is a movie. In markets with few buyers, unique offerings, or high switching costs, he argues for a collaborative split - sharing value openly enough that the customer keeps coming back. In high-volume markets, segmentation and elasticity do more work. The answer is contextual, and pretending otherwise leaves money, or trust, on the table.
There is an intellectual honesty in this that runs through everything he says. He readily concedes that value estimates start rough. “The quality of our estimates will improve over time,” he writes - not the kind of line a vendor selling certainty usually offers. For Marshall, the point is not to fake precision. It is to give buyers and sellers a shared, improvable model they can argue over with real numbers instead of adjectives.
Marshall founded LeveragePoint in 2009 and has run it with a patience that looks almost contrarian in B2B software. The company took a small seed round - its total outside funding sits around seven hundred thousand dollars - and then largely grew on its own revenue rather than chasing the next venture check. In a category where the reflex is to raise big and burn fast, he built something that compounds quietly. It is the founder equivalent of his own pricing thesis: think in movies, not snapshots.
The platform itself has grown into a toolkit for the whole value chain. Marketing teams use it to craft digital value propositions. Sales teams use it for interactive ROI tools and value stories they can run live in a meeting. Product teams use value maps to understand where they actually differ from a competitor. Customer-success teams use it to prove that the value promised before the sale showed up after it. The connective tissue is Marshall's conviction that value should not be a slide you present once and forget. It should be a model the customer keeps using.
It is a precise, almost professorial mission - which is fitting for a man who has been a professor. LeveragePoint is not trying to be loud. It is trying to be right, repeatedly, in a corner of business that most people would rather hand-wave through. Marshall has been making the same argument for years: in a B2B sale, the strongest case you can make is one the customer can verify. Brochures persuade for a meeting. Math persuades for a contract.
That is the throughline of an unusual career. Davidson to MIT. The lecture hall to the trading floor. The CFO's chair through an IPO and a drug launch. And finally a software company built on the stubborn belief that value, honestly measured, is the most underused argument in commerce. Peyton Marshall did not invent value-based pricing. He did something harder - he made it something a sales team will actually open on a Tuesday.
// Marshall's argument: the right approach depends on your market. There is no magic percentage.
A single deal. Psychology, competition, and cost set the price in the moment. Useful, but blind to everything that happens next.
Many transactions over time. Segmentation and demand elasticity do the work. Strategy beats the one-off negotiation.
Few buyers, unique offerings, high switching costs. Share value openly so the customer keeps choosing you.
// Illustrative - the teams LeveragePoint is built to connect across the value chain.
Value brings the customer's business into focus and highlights our differentiation.
What percent of value should we capture in price? Framing the question influences the outcomes.
The quality of our estimates will improve over time.
A single sale is a snapshot. A business is a movie.